We are live on ! Find out more
CL icon

Colgate-Palmolive

1,741 hedge funds and large institutions have $54.9B invested in Colgate-Palmolive in 2023 Q4 according to their latest regulatory filings, with 228 funds opening new positions, 562 increasing their positions, 642 reducing their positions, and 87 closing their positions.

New
Increased
Maintained
Reduced
Closed

172% more call options, than puts

Call options by funds: $1.12B | Put options by funds: $412M

162% more first-time investments, than exits

New positions opened: 228 | Existing positions closed: 87

16% more capital invested

Capital invested by funds: $47.5B → $54.9B (+$7.41B)

7% more funds holding

Funds holding: 1,6211,741 (+120)

3.04% more ownership

Funds ownership: 80.51%83.55% (+3%)

0% more funds holding in top 10

Funds holding in top 10: 1010 (0)

12% less repeat investments, than reductions

Existing positions increased: 562 | Existing positions reduced: 642

Holders
1,741
Holders Change
+120
Holders Change %
+7.4%
% of All Funds
25.38%
Holding in Top 10
10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.15%
New
228
Increased
562
Reduced
642
Closed
87
Calls
$1.12B
Puts
$412M
Net Calls
+$707M
Net Calls Change
+$816M
Name Holding Trade Value Shares
Change
Change in
Stake
IIM
526
Intact Investment Management
Quebec, Canada
$2.59M +$1.34M +17,800 +121%
JCM
527
Jag Capital Management
Missouri
$2.58M +$4.96K +66 +0.2%
GT
528
Greenleaf Trust
Michigan
$2.58M +$173K +2,301 +8%
Credit Agricole
529
Credit Agricole
France
$2.58M +$1.22M +16,167 +100%
CFB
530
Cullen/Frost Bankers
Texas
$2.56M +$32.8K +436 +1%
ACM
531
Ayrshire Capital Management
Connecticut
$2.54M -$377K -5,020 -14%
IAA
532
Independent Advisor Alliance
North Carolina
$2.53M -$427K -5,678 -15%
ECM
533
EagleClaw Capital Management
Massachusetts
$2.52M +$180K +2,400 +8%
GW
534
GW & Wade
Massachusetts
$2.5M -$110K -1,464 -4%
ACA
535
Anchor Capital Advisors
Massachusetts
$2.5M -$170K -2,255 -7%
ADL
536
Asset Dedication LLC
California
$2.49M -$128K -1,702 -5%
GIA
537
GHP Investment Advisors
Colorado
$2.49M -$1.05M -13,986 -31%
EWM
538
Evercore Wealth Management
New York
$2.49M -$69.1K -919 -3%
EOJOAM
539
E. Ohman J:or Asset Management
Sweden
$2.46M -$383K -5,100 -14%
SAM
540
Shell Asset Management
Netherlands
$2.44M -$1.58M -20,976 -41%
ANTB
541
AMG National Trust Bank
Colorado
$2.41M +$9.85K +131 +0.4%
FTDI
542
First Trust Direct Indexing
Massachusetts
$2.41M +$454K +6,033 +25%
MFIM
543
Mesirow Financial Investment Management
Illinois
$2.41M +$3.52M +46,757 New
IC
544
IEQ Capital
California
$2.4M +$160K +2,127 +8%
LOAMS
545
Lombard Odier Asset Management (Switzerland)
Switzerland
$2.39M +$2.26M +30,037 New
MCM
546
MAI Capital Management
Ohio
$2.39M +$367K +4,883 +19%
LBC
547
Lowe Brockenbrough & Co
Virginia
$2.38M -$3.76K -50 -0.2%
HCM
548
Howland Capital Management
Massachusetts
$2.38M -$75.2K -1,000 -3%
YIA
549
YHB Investment Advisors
Connecticut
$2.37M -$742K -9,862 -25%
AWM
550
Apollon Wealth Management
South Carolina
$2.35M +$1.08M +14,407 +96%

CL Hedge Fund Activity: Q4 2023 in Review

1,741 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Colgate-Palmolive (CL) for Q4 2023, worth a combined $54.9B — up 16% from $47.5B a quarter earlier.

Buyers outnumbered sellers: 228 funds opened new CL positions and 87 closed out — a net gain of 141 holders — while 562 added to existing stakes and 642 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $1.65B. The largest seller was Wellington Management Group, cutting an estimated $303M.

  • 1,741 institutional investors held Colgate-Palmolive (CL) as of Q4 2023, up from 1,621 in Q3 2023.
  • Funds reported $54.9B of Colgate-Palmolive stock for Q4 2023, up 16% quarter-over-quarter.
  • 228 funds opened new Colgate-Palmolive positions in Q4 2023 and 87 closed out, a net change of +141 holders.
  • The largest Colgate-Palmolive buyer in Q4 2023 was Morgan Stanley, an estimated $1.65B added.
  • The largest Colgate-Palmolive seller in Q4 2023 was Wellington Management Group, an estimated $303M sold.

Based on aggregated 13F filings for Q4 2023.